2001
DOI: 10.1046/j.1523-1755.2001.00936.x
|View full text |Cite
|
Sign up to set email alerts
|

Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and βblockers

Abstract: The beneficial effect of non-hypotensive doses of alpha and beta blockers and their combination on renal morphology and albuminuria in the model of renal ablation argue for a blood pressure-independent role of sympathetic overactivity in the genesis of progression. In addition, the beneficial effect of adrenergic receptor blockade indicates that a substantial part is not mediated by sympathetic cotransmitters such as adenosine 5'-triphosphate (ATP) and neuropeptide Y (NPY).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
88
0
1

Year Published

2003
2003
2011
2011

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 98 publications
(97 citation statements)
references
References 40 publications
8
88
0
1
Order By: Relevance
“…It is known that the sympathetic nervous system is overactive in patients with chronic renal damage. 25 Amman et al 26 reported that alpha-and beta-blockers, and their combination, had a beneficial effect on renal morphology and albuminuria in a rat model of renal ablation. Moreover, it has been reported that OHT might be associated with overactivity of the sympathetic nervous system.…”
Section: Discussionmentioning
confidence: 99%
“…It is known that the sympathetic nervous system is overactive in patients with chronic renal damage. 25 Amman et al 26 reported that alpha-and beta-blockers, and their combination, had a beneficial effect on renal morphology and albuminuria in a rat model of renal ablation. Moreover, it has been reported that OHT might be associated with overactivity of the sympathetic nervous system.…”
Section: Discussionmentioning
confidence: 99%
“…17,18 Analysis of glomerular capillarization and cellularity on semithin sections On five semithin sections per animal, glomerular capillarization and cellularity were analyzed using the point counting method and a 100-point eyepiece (Integrationsplatte II; Zeiss Co.) at a magnification of  1000 (oil immersion) as described previously. 19 Briefly, the length density (L v …”
Section: Glomerular Geometrymentioning
confidence: 99%
“…18,19 Briefly, total RNA (1 mg) was dissolved in 20 ml of a reaction mixture containing 4 mM dATP, dCTP, dTTP and dGTP; 10 U RNAsin (Life Technologies BLR, Grand island, NY, USA); 100 pmol random hexamers (Boehringer Mannheim GmbH, Mannheim, Germany); PCR buffer (final concentrations: 1.6 mM (NH 4 ) 2 SO 4 , 2.0 mM Tris-HCl (pH 8.4), 1.5 mM MgCl 2 ); and 100 U Superscript reverse transcriptase (Life Technologies BLR). After incubation at 421C for 45 min, the enzyme was denatured for 5 min at 941C.…”
Section: Immunohistochemical Investigationsmentioning
confidence: 99%
“…The volume density of the various cell types (V VCell ) and the cell density per volume (N VCell ) were determined according to the equation N VCell ϭ k/␤ ϫ N ACell 1.5 /V VCell 0.5 , with ␤ ϭ 1.5 for podocytes, ␤ ϭ 1.4 for mesangial and endothelial cells, and k ϭ 1 (19) …”
Section: Glomerular Capillarization Cellularity and Cell Proliferationmentioning
confidence: 99%
“…The vessel area (A vessel ) and lumen area (A lumen ) were determined with the equations A vessel ϭ ϫ (D outer /2) 2 and A lumen ϭ ϫ (D inner /2) 2 , respectively (D outer , distance from one outer site of the vessel to the opposite site; D inner , distance from one inner site of the vessel to the opposite site; D max , D outer Ϫ D inner at the largest vessel diameter; D min , D outer Ϫ D inner at the smallest vessel diameter). The lumen of the vessel was calculated as the difference of the two (19).…”
Section: Quantitative Analysis Of the Renal Vasculaturementioning
confidence: 99%